Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lasermedics

This article was originally published in The Gray Sheet

Executive Summary

Plans to submit a premarket approval application to FDA within 90 days for its Microlight 830 nonsurgical cold laser for the treatment of repetitive stress injuries, including carpel tunnel syndrome. The Missouri City, Texas firm says that the device's 510(k) submission, submitted in September 1993, was deemed "not substantially equivalent" by the agency. The PMA will include data from a General Motors study involving 160 patients with chronic CTS. In addition, Lasermedics plans to submit a protocol to the agency by Feb. 1 to expand ongoing clinical trials for the Microlight to include additional conditions such as arthritis, wound healing and periodontal disease
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003158

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel